Barrington Research Weighs in on Henry Schein Q3 Earnings

Key Points

• Barrington Research has increased its Q3 2025 earnings per share estimate for Henry Schein to $1.27, with a price target of $78.00 and an "Outperform" rating.
• The company reported $1.10 EPS in its latest quarter, falling short of expectations by ($0.09), though revenue increased 3.3% year-over-year to $3.24 billion.
• Institutional ownership of Henry Schein is strong, with approximately 96.62% of the stock held by hedge funds and other institutional investors, indicating significant confidence in the company's prospects.

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Barrington Research increased their Q3 2025 earnings per share estimates for Henry Schein in a research note issued on Wednesday, August 6th. Barrington Research analyst M. Petusky now expects that the company will post earnings per share of $1.27 for the quarter, up from their prior forecast of $1.25. Barrington Research has a "Outperform" rating and a $78.00 price target on the stock. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein's FY2025 earnings at $4.81 EPS, Q2 2026 earnings at $1.26 EPS, FY2026 earnings at $5.21 EPS and FY2027 earnings at $5.62 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The company had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the prior year, the business posted $1.23 earnings per share. The company's revenue for the quarter was up 3.3% on a year-over-year basis.

Several other equities research analysts have also weighed in on the company. UBS Group dropped their price target on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. JPMorgan Chase & Co. lowered their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research report on Thursday. Evercore ISI decreased their target price on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a research note on Wednesday, August 6th. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Piper Sandler dropped their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $75.58.

Henry Schein Stock Performance

Henry Schein stock opened at $65.94 on Monday. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The stock's 50 day simple moving average is $71.07 and its two-hundred day simple moving average is $71.06. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The stock has a market cap of $8.00 billion, a price-to-earnings ratio of 21.27, a PEG ratio of 2.17 and a beta of 0.81.

Institutional Trading of Henry Schein

Institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC grew its stake in shares of Henry Schein by 237.3% in the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after acquiring an additional 1,898 shares during the period. State of Alaska Department of Revenue boosted its holdings in Henry Schein by 2.8% in the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after purchasing an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in Henry Schein by 5.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after purchasing an additional 678 shares during the period. GAMMA Investing LLC raised its stake in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after buying an additional 1,081 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of Henry Schein by 12.6% during the 4th quarter. Wellington Management Group LLP now owns 6,902 shares of the company's stock valued at $478,000 after buying an additional 775 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.